{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:23:18Z","timestamp":1761765798705},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1745-6215-15-238","type":"journal-article","created":{"date-parts":[[2014,6,20]],"date-time":"2014-06-20T07:04:28Z","timestamp":1403247868000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Use of drug therapy in the management of symptomatic ureteric stones in hospitalized adults (SUSPEND), a multicentre, placebo-controlled, randomized trial of a calcium-channel blocker (nifedipine) and an \u03b1-blocker (tamsulosin): study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"15","author":[{"name":"the SUSPEND Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"McClinton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Starr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme","family":"McLennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gladys","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"N\u2019Dow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Kilonzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Pickard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Anson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Burr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,20]]},"reference":[{"key":"2136_CR1","first-page":"3229","volume-title":"Campbell\u2019s Urology","author":"M Menon","year":"2002","unstructured":"Menon M, Resnick MI: Urinary lithiasis: etiology, diagnosis, and medical and management. Campbell\u2019s Urology. Edited by: Walsh PC, Retik AB, Vaughan EDJr, Wein AJ. 2002, Philadelphia: WB Saunders Co, 3229-8","edition":"8"},{"key":"2136_CR2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1258\/0004563011900623","volume":"38","author":"H Wilkinson","year":"2001","unstructured":"Wilkinson H: Clinical investigation and management of patients with renal stones. Ann Clin Biochem. 2001, 38: 180-187. 10.1258\/0004563011900623.","journal-title":"Ann Clin Biochem"},{"key":"2136_CR3","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0140-6736(01)05782-8","volume":"358","author":"G Bihl","year":"2001","unstructured":"Bihl G, Meyers A: Recurrent renal stone disease-advances in pathogenesis and clinical management. Lancet. 2001, 358: 651-656. 10.1016\/S0140-6736(01)05782-8.","journal-title":"Lancet"},{"key":"2136_CR4","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1046\/j.1523-1755.2003.00917.x","volume":"63","author":"KK Stamatelou","year":"2003","unstructured":"Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC: Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003, 63: 1817-1823. 10.1046\/j.1523-1755.2003.00917.x.","journal-title":"Kidney Int"},{"key":"2136_CR5","unstructured":"Hospital Episode Statistics (HES) Online.\n                    http:\/\/www.hscic.gov.uk\/hes\n                    \n                  ,"},{"issue":"52","key":"2136_CR6","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.eururo.2007.09.039","volume":"2007","author":"GM Preminger","year":"2007","unstructured":"Preminger GM, Tiselius HG, Assimos DG, Alken P, Buck AC, Gallucci M, Knoll T, Lingeman JE, Nakada SY, Pearle MS, Sarica K, T\u00fcrk C, Wolf JS, American Urological Association Education and Research, Inc, European Association of Urology: 2007 guideline for the management of ureteral calculi. Eur Urol. 2007, 2007 (52): 1610-1631.","journal-title":"Eur Urol"},{"issue":"suppl 5","key":"2136_CR7","first-page":"472A","volume":"155","author":"K Obara","year":"1996","unstructured":"Obara K, Takeda M, Shimura H, Kanai T, Tsutsui T, Komeyama T: Alpha-1 adrenoreceptor subtypes in the human ureter: characterization by RT-PCR and in situ hybridization. J Urol. 1996, 155 (suppl 5): 472A-abstract 646","journal-title":"J Urol"},{"key":"2136_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/nau.20097","volume":"24","author":"S Sigala","year":"2005","unstructured":"Sigala S, Dellabella M, Milanese G, Fornari S, Faccoli S, Palazzolo F, Peroni A, Mirabella G, Cunico SC, Spano P, Muzzonigro G: Evidence for the presence of \u03b11 adrenoceptor subtypes in the human ureter. Neurourol Urodyn. 2005, 24: 142-148. 10.1002\/nau.20097.","journal-title":"Neurourol Urodyn"},{"key":"2136_CR9","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/j.1442-2042.2007.01812.x","volume":"14","author":"Y Itoh","year":"2007","unstructured":"Itoh Y, Kojima Y, Yasui T, Tozawa K, Sasaki S, Kohri K: Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol. 2007, 14: 749-753. 10.1111\/j.1442-2042.2007.01812.x.","journal-title":"Int J Urol"},{"key":"2136_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/(SICI)1097-0045(19970915)33:1<55::AID-PROS9>3.0.CO;2-8","volume":"33","author":"CD Richardson","year":"1997","unstructured":"Richardson CD, Donatucci CF, Page SO, Wilson KH, Schwinn DA: Pharmacology of tamsulosin: saturation-binding isotherms and competition analysis using cloned \u03b11-adrenergic receptor subtypes. Prostate. 1997, 33: 55-59. 10.1002\/(SICI)1097-0045(19970915)33:1<55::AID-PROS9>3.0.CO;2-8.","journal-title":"Prostate"},{"key":"2136_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/sj.bjp.0700907","volume":"120","author":"AJ Noble","year":"1997","unstructured":"Noble AJ, Chess-Williams R, Couldwell C, Furukawa K, Uchyiuma T, Korstanje C, Chapple CR: The effects of tamsulosin, a high affinity antagonist at functional \u03b11A- and \u03b11D-adrenoceptor subtypes. Br J Pharmacol. 1997, 120: 231-238. 10.1038\/sj.bjp.0700907.","journal-title":"Br J Pharmacol"},{"key":"2136_CR12","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/j.1365-2125.1982.tb01439.x","volume":"13","author":"HL Elliott","year":"1982","unstructured":"Elliott HL, Meredith PA, Sumner DJ, McLean K, Reid JL: A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects. Br J Clin Pharmacol. 1982, 13: 699-703. 10.1111\/j.1365-2125.1982.tb01439.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"6 Suppl","key":"2136_CR13","first-page":"21","volume":"32","author":"H Lepor","year":"1988","unstructured":"Lepor H, Gup DI, Baumann M, Shapiro E: Laboratory assessment of terazosin and alpha-1 blockade in prostatic hyperplasia. Urology. 1988, 32 (6 Suppl): 21-26.","journal-title":"Urology"},{"key":"2136_CR14","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/j.1476-5381.1993.tb13762.x","volume":"109","author":"F Lef\u00e8vre-Borg","year":"1993","unstructured":"Lef\u00e8vre-Borg F, O'Connor SE, Schoemaker H, Hicks PE, Lechaire J, Gautier E, Pierre F, Pimoule C, Manoury P, Langer SZ: Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tract. Br J Pharmacol. 1993, 109: 1282-1289. 10.1111\/j.1476-5381.1993.tb13762.x.","journal-title":"Br J Pharmacol"},{"key":"2136_CR15","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0022-5347(17)50120-2","volume":"132","author":"L Hertle","year":"1984","unstructured":"Hertle L, Nawrath H: Calcium channel blockade in smooth muscle of the human upper urinary tract. I. Effects on depolarization-induced activation. J Urol. 1984, 132: 1265-1269.","journal-title":"J Urol"},{"key":"2136_CR16","first-page":"150","volume":"13","author":"S Salman","year":"1989","unstructured":"Salman S, Castilla C, Vela Navarrete R: Action of calcium antagonists on ureteral dynamics. Actas Urol Esp. 1989, 13: 150-152.","journal-title":"Actas Urol Esp"},{"key":"2136_CR17","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0140-6736(06)69474-9","volume":"368","author":"JM Hollingsworth","year":"2006","unstructured":"Hollingsworth JM, Rogers MA, Kaufman SR, Bradford TJ, Saint S, Wei JT, Hollenbeck BK: Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet. 2006, 368: 1171-1179. 10.1016\/S0140-6736(06)69474-9.","journal-title":"Lancet"},{"key":"2136_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.annemergmed.2007.05.015","volume":"50","author":"A Singh","year":"2007","unstructured":"Singh A, Alter HJ, Littlepage A: A systematic review of medical therapy to facilitate passage of ureteral calculi. Ann Emerg Med. 2007, 50: 552-563. 10.1016\/j.annemergmed.2007.05.015.","journal-title":"Ann Emerg Med"},{"issue":"3","key":"2136_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1569-9056(08)60312-7","volume":"7","author":"S Vincendeau","year":"2008","unstructured":"Vincendeau S, Bellissant E, Bensalah K, Houlgatte A, Dor\u00e9 B, Bruyere F, Patard J, Guill\u00e9 F: Lack of efficacy of tamsulosin in the treatment of distal ureteral stones. Eur Urol Suppl. 2008, 7 (3): 149-","journal-title":"Eur Urol Suppl"},{"key":"2136_CR20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.eururo.2007.09.012","volume":"53","author":"K Bensalah","year":"2008","unstructured":"Bensalah K, Pearle M, Lotan Y: Cost-effectiveness of medical expulsive therapy using alpha-blockers for the treatment of distal ureteral stones. Eur Urol. 2008, 53: 411-418. 10.1016\/j.eururo.2007.09.012.","journal-title":"Eur Urol"},{"key":"2136_CR21","volume-title":"The Rule Governing Medicinal Products in the EU: Good Manufacturing Practices. Volume 4, Annex 13","author":"EudraLex","year":"2010","unstructured":"EudraLex: The Rule Governing Medicinal Products in the EU: Good Manufacturing Practices. Volume 4, Annex 13. 2010, Brussels: European Commission,\n                    http:\/\/ec.europa.eu\/health\/documents\/eudralex\/vol-4\/index_en.htm\n                    \n                  ,"},{"issue":"6514","key":"2136_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0140-6736(48)91787-5","volume":"252","author":"KD Keele","year":"1948","unstructured":"Keele KD: The pain chart. Lancet. 1948, 252 (6514): 6-8. 10.1016\/S0140-6736(48)91787-5.","journal-title":"Lancet"},{"key":"2136_CR23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/ard.37.4.378","volume":"37","author":"WW Downie","year":"1978","unstructured":"Downie WW, Leathem PA, Rhind PA: Studies with pain rating scales. Ann Rheum Dis. 1978, 37: 378-381. 10.1136\/ard.37.4.378.","journal-title":"Ann Rheum Dis"},{"key":"2136_CR24","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S0140-6736(05)66461-6","volume":"365","author":"K Schulz","year":"2005","unstructured":"Schulz K, Grimes D: Multiplicity in randomised trials I: endpoints and treatments. Lancet. 2005, 365: 1591-1595. 10.1016\/S0140-6736(05)66461-6.","journal-title":"Lancet"},{"key":"2136_CR25","unstructured":"Department for Health: NHS Pay Review Body, Twenty-Sixth Report 2012.\n                    https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/228908\/8298.pdf\n                    \n                  ,"},{"key":"2136_CR26","unstructured":"Value of time and operating costs: transport analysis guidance (TAG).\n                    http:\/\/www.dft.gov.uk\/webtag\/documents\/archive\/1208\/unit3.5.6.pdf\n                    \n                  ,"},{"key":"2136_CR27","unstructured":"Office for National Statistics Statistical Bulletin: Annual Survey of Hours and Earnings, 2013 Provisional Results.\n                    http:\/\/www.ons.gov.uk\/ons\/dcp171778_335027.pdf\n                    \n                  ,"},{"key":"2136_CR28","volume-title":"Centre for Health Economics Discussion Paper 172","author":"P Kind","year":"1999","unstructured":"Kind P, Hardman G, Macran S: UK population norms for EQ-5D. Centre for Health Economics Discussion Paper 172. 1999, York: University of York"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-15-238.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T03:37:49Z","timestamp":1548214669000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-15-238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,20]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2136"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-15-238","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2014,6,20]]},"assertion":[{"value":"28 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"238"}}